Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsHematopoiesisCytarabineHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationWhole-Body IrradiationTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateInfectionSurvival AnalysisLymphoma, T-CellTime FactorsDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicVidarabineDexamethasoneBlood Cell CountRecombinant ProteinsFollow-Up StudiesLeukemiaBone Marrow PurgingAntineoplastic AgentsLymphomaProspective StudiesBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesAnemia, AplasticImmunophenotypingBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLiver TransplantationT-LymphocytesLeukocytes, MononuclearHematologic DiseasesHistiocytosis, Non-Langerhans-CellLivedo ReticularisBone MarrowOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensCyclosporinePrognosisBlood DonorsImmunosuppressionBreast NeoplasmsMesenchymal Stem Cell TransplantationCell Separation